The symptoms can vary in severity among individuals ... A 2024 study investigated drivers of fatigue in patients with psoriasis and psoriatic arthritis. Researchers found that fatigue was more ...
and characteristic symptoms. The lack of a validated case definition for PsA has posed significant challenges for scientific and clinical research in the field. However, progress was made in 2006 when ...
UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...
Patients with inadequate response entered early escape at week 16. The primary measure of clinical response was ACR20. Other measures included Psoriatic Arthritis Response Criteria (PsARC), Psoriasis ...
Psoriasis-associated comorbidities can have a significant impact on a patient's quality of life. Clinicians should be aware of these co-existing conditions for screening and appropriate co-management.